Dubai Thoracic Congress Marks Region’s Breakthrough in Robotic Lung Surgery

The Emirates Thoracic Society's annual gathering celebrates the UAE's adoption of cutting-edge robotically-assisted bronchoscopy technology and reflects the nation's emerging leadership in respiratory medicine innovation.

A convergence of more than 650 respiratory and thoracic specialists from across the globe gathered in Dubai this week for the 2026 Emirates Thoracic Society Annual Congress, an occasion that crystallised the UAE’s increasingly prominent role in advancing global standards of pulmonary healthcare. The event, inaugurated by Sheikha Dr. Noura Khalid Al Qasimi, President of the Emirates Medical Association, marked a watershed moment: the introduction at Cleveland Clinic Abu Dhabi of robotically-assisted bronchoscopy technology, positioning the UAE as the first nation in the Gulf Cooperation Council region and the Middle East to embrace this transformative approach to early lung cancer detection.

The technology represents a profound shift in diagnostic capability. By enabling physicians to access the smallest lung nodules deep within the lungs, often the earliest visible signs of malignancy, it permits accurate diagnosis at nascent stages without requiring open surgery. This precision matters profoundly: patients can move swiftly from detection to intervention, while the non-invasive nature of the procedure spares them the trauma and recovery demands of traditional surgical approaches.

Across two days, the congress created space for dynamic scientific discourse. More than twenty international experts joined regional specialists to discuss emerging research and breakthroughs, to strengthen multidisciplinary collaboration and to support the educational advancement of respiratory medicine across the region. The breadth of topics reflected the complexity of modern thoracic care: from interventional bronchoscopy procedures to the management of interstitial lung diseases, from advances in chronic obstructive pulmonary disease treatment to paediatric respiratory medicine.

Prof. Ashraf Alzaabi, President of the Emirates Thoracic Society, drew attention to further achievements that underscore the nation’s medical progression. Since September, the UAE has become one of only three countries worldwide to use advanced medications for treating lung cancer and pulmonary fibrosis, a distinction that speaks to both the clinical acumen within the nation’s institutions and the commitment of its leadership to ensuring patients access the most sophisticated therapeutic options available.

The congress also honoured innovation through its Annual Award for Research and Innovation in Respiratory Medicine, recognising visionaries and leaders advancing respiratory medicine. Beyond celebration, this recognition serves a vital purpose: accelerating translational research and bridging the gap between scientific discovery and clinical application.

Of particular note is collaborative research currently underway between the Emirates Thoracic Society, Khalifa University and the Department of Health – Abu Dhabi. This work focuses on genetic variations associated with airway diseases within the UAE population, comparing local findings with global genetic patterns to develop more accurate, personalised treatment predictions. Such endeavours strengthen the intellectual foundations upon which the nation’s healthcare improvements rest.

The availability of lung cancer screening centres employing computed tomography scans across the UAE, particularly supporting smokers seeking early detection, complements these clinical innovations. Together, these developments reflect a healthcare system increasingly oriented toward prevention, early intervention and evidence-based excellence.

What it means for Abu Dhabi

The adoption of robotically-assisted bronchoscopy technology at Cleveland Clinic Abu Dhabi positions the emirate at the forefront of regional medical innovation, attracting patients seeking the most advanced diagnostic capabilities and reinforcing Abu Dhabi’s reputation as a global hub for sophisticated healthcare delivery. This technological leadership enhances the city’s competitive standing in medical tourism and demonstrates the calibre of clinical expertise available within its institutions.

The research initiatives linking the Emirates Thoracic Society with Khalifa University and the Department of Health – Abu Dhabi signal an emerging framework for knowledge creation rooted in local populations and conditions. By understanding genetic variations specific to the UAE, healthcare providers can move beyond population-generic approaches toward treatments tailored to regional populations, ultimately improving outcomes for Abu Dhabi’s residents and contributing to global medical knowledge.

Source: Emirates News Agency